These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25956192)

  • 1. Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes.
    Li Q; Tang Q; Zhang P; Wang Z; Zhao T; Zhou J; Li H; Ding Q; Li W; Hu F; Du Y; Yuan H; Chen S; Gao J; Zhan J; You J
    Biomaterials; 2015 Jul; 57():1-11. PubMed ID: 25956192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy.
    You J; Zhang P; Hu F; Du Y; Yuan H; Zhu J; Wang Z; Zhou J; Li C
    Pharm Res; 2014 Mar; 31(3):554-65. PubMed ID: 24022681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.
    You J; Zhang R; Zhang G; Zhong M; Liu Y; Van Pelt CS; Liang D; Wei W; Sood AK; Li C
    J Control Release; 2012 Mar; 158(2):319-28. PubMed ID: 22063003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-specific near-IR induced drug release and photothermal therapy with accumulated Au/Ag hollow nanoshells on pulmonary cancer cell membranes.
    Noh MS; Lee S; Kang H; Yang JK; Lee H; Hwang D; Lee JW; Jeong S; Jang Y; Jun BH; Jeong DH; Kim SK; Lee YS; Cho MH
    Biomaterials; 2015 Mar; 45():81-92. PubMed ID: 25662498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cells.
    Lee YH; Ma YT
    J Nanobiotechnology; 2017 May; 15(1):41. PubMed ID: 28521752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
    Shmeeda H; Tzemach D; Mak L; Gabizon A
    J Control Release; 2009 Jun; 136(2):155-60. PubMed ID: 19331844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
    Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
    Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
    Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
    Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect.
    Kwon HJ; Byeon Y; Jeon HN; Cho SH; Han HD; Shin BC
    J Control Release; 2015 Oct; 216():132-9. PubMed ID: 26247553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
    Bai J; Liu Y; Jiang X
    Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucumber mosaic virus as drug delivery vehicle for doxorubicin.
    Zeng Q; Wen H; Wen Q; Chen X; Wang Y; Xuan W; Liang J; Wan S
    Biomaterials; 2013 Jun; 34(19):4632-42. PubMed ID: 23528229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated hyaluronidase/NIR induced drug controlled release system for synergetic chemo-photothermal therapy of hepatocellular carcinoma.
    Li H; Li H; Yu W; Huang S; Liu Y; Zhang N; Yuan J; Xu X; Duan S; Hu Y
    Eur J Pharm Sci; 2019 May; 133():127-136. PubMed ID: 30779981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.